Clinical Trial Update: MiDeTe - microRNA Levels Under Denosumab and Teriparatide Therapy in Postmenopausal Osteoporosis [Phase 4]

View source ↗

Summary

Phase 4 trial evaluating microRNA levels under denosumab and teriparatide therapy in postmenopausal osteoporosis (completed).

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Diabetes Type 2
• Postmenopausal Osteoporosis

Drugs mentioned

• Denosumab (denosumab)
• Teriparatide (Teriparatide)

Snippet

Sponsor: Medical University of Vienna | Conditions: Postmenopausal Osteoporosis, Diabetes Type 2 | Phase 4 | Status: COMPLETED